Comparing of moxifloxacin and azythromycin against urogenital chlamydia trachomatis
Quanzhong Liu
Abstract
Quanzhong Liu
Abstract
Objective: To compare the effects of moxifloxacin and azythromycin in treating with urogenital chlamydia trachomatis.Methods: The data of 1 671 patients who were insured to have got urogenital chlamydia trachomatis infection and treated with moxifloxacin or azythromycin were collected and the effects of the two antibiotics were analyzed with descriptive epidemiological method.Results: The etiology cure rate of moxifloxacin was 83.61%,that of azythromycin was 73.28%.What's more,their effects decreased year by year.The clinical cure rate of moxifloxacin was 74.88%,that of azythromycin was 88.91%.Conclusion: The etiology cure rate of moxifloxacin is higher than that of azythromycin,but the clinical cure rate of moxifloxacin is lower than that of azythromycin.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To compare the effects of moxifloxacin and azythromycin in treating with urogenital chlamydia trachomatis.Methods: The data of 1 671 patients who were insured to have got urogenital chlamydia trachomatis infection and treated with moxifloxacin or azythromycin were collected and the effects of the two antibiotics were analyzed with descriptive epidemiological method.Results: The etiology cure rate of moxifloxacin was 83.61%,that of azythromycin was 73.28%.What's more,their effects decreased year by year.The clinical cure rate of moxifloxacin was 74.88%,that of azythromycin was 88.91%.Conclusion: The etiology cure rate of moxifloxacin is higher than that of azythromycin,but the clinical cure rate of moxifloxacin is lower than that of azythromycin.
Key concepts: Moxifloxacin, Chlamydia trachomatis, Medicine, Chlamydia, Cure rate, Genitourinary system, Etiology, Internal medicine